foxo4-dri peptide senolytic human trial The disordered p53 transactivation domain is the target of FOXO4 and the compound FOXO4-DRI improves spermatogenesis in aged
Pay in 4 interest-free payments of $6.25 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10




















